PTEN and osteosarcoma: In summary, our study revealed that inhibition of GSK-3β might suppress the osteosarcoma invasion and migration via the pathways associated with PTEN and phosphorylation of focal adhesion kinase, followed by reduced expression of MMP-2 or MMP-9.